Steve Dubin serves as Executive at MARTEK BIOSCIENCES CORP, where they oversee executive responsibilities. Since joining the company, Steve Dubin has executed 16 insider transactions totaling $215.5K, demonstrating a bullish approach to their equity position. Their most recent transaction on Jun 5, 2024 involved receiving (via award) 5,900 shares valued at $0.
Steve Dubin currently holds 16,800 shares of MARTEK BIOSCIENCES CORP (MATK), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Steve Dubin has been a net buyer of MATK stock. They have purchased $215.5K and sold $0 worth of shares.
Steve Dubin's most recent insider trade was on Jun 5, 2024, when they sold 5,900 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $2.40 |
| Discretionary |
| Jun 1, 2023 | ACET | $0 | Award | 5,900 | $N/A | Discretionary |
| Feb 25, 2011 | MATK | $1.6M | Disposition | 52,247 | $31.50 | Discretionary |
| Feb 25, 2011 | MATK | $0 | Award | 52,247 | $N/A | Discretionary |
| Feb 18, 2011 | MATK | $1.0M | Tender | 32,462 | $31.50 | Discretionary |
| Jul 7, 2010 | MATK | $41.9K | Purchase | 2,000 | $20.96 | Discretionary |
| Mar 19, 2010 | MATK | $0 | Option Exercise | 9,431 | $N/A | Discretionary |
| Mar 19, 2010 | MATK | $73.8K | Payment | 3,089 | $23.88 | Discretionary |
| Mar 19, 2009 | MATK | $36.4K | Payment | 2,131 | $17.07 | Discretionary |
| Mar 19, 2009 | MATK | $0 | Option Exercise | 6,191 | $N/A | Discretionary |
| Mar 19, 2008 | MATK | $0 | Option Exercise | 3,599 | $N/A | Discretionary |
| Mar 19, 2008 | MATK | $37.7K | Payment | 1,239 | $30.39 | Discretionary |
| Dec 18, 2007 | MATK | $28.1K | Purchase | 1,000 | $28.15 | Discretionary |
| Mar 30, 2007 | MATK | $50.7K | Purchase | 2,500 | $20.28 | Discretionary |
| Sep 11, 2006 | MATK | $82.8K | Purchase | 4,000 | $20.69 | Discretionary |